More Than High and Low Risk: How We Have Learned That Endometrial Cancer Is Not a Single Malignancy

Avsnitt

Living With Endometrial Cancer: Understanding Patient Perspectives to Improve Overall Care
15 feb 2024· Breaking the Silence: Navigating Advanced Endometrial Cancer
Join for a discussion on the impact of endometrial cancer (EC) on patients' quality of life (QoL).

Credit available for this activity expires: 2/15/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000137?ecd=bdc_podcast_libsyn_mscpedu
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
More Than High and Low Risk: How We Have Learned That Endometrial Cancer Is Not a Single Malignancy
22 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
The experts discuss subtypes and molecular classification of endometrial cancer (EC).

Credit available for this activity expires: 12/22/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999291?ecd=bdc_podcast_libsyn_mscpedu
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Saknas det avsnitt?

Klicka här för att uppdatera flödet manuellt.
Beyond Primary Treatment: How Else Can We Benefit Our Patients Through a Holistic Approach to Care?
20 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
The experts discuss how to support patients during treatment for endometrial cancer (EC).

Credit available for this activity expires: 12/20/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999343?ecd=bdc_podcast_libsyn_mscpedu
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
The Hottest Topic in Endometrial Cancer: Where Is the Therapeutic Landscape Moving to and What Are the Data to Support This?
20 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
The experts discuss recent clinical trial data in endometrial cancer (EC).

Credit available for this activity expires: 12/20/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999338?ecd=bdc_podcast_libsyn_mscpedu
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
To Combine or Not to Combine Chemotherapy and Immunotherapy, Is That the Question in Endometrial Cancer?
19 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
Join the experts for a discussion chemotherapy and immunotherapy in treating metastatic endometrial cancer (EC).

Credit available for this activity expires: 12/19/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999289?ecd=bdc_podcast_libsyn_mscpedu
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
The Story So Far: The Long and Short of Clinical Development in Endometrial Cancer
11 dec 2023· Breaking the Silence: Navigating Advanced Endometrial Cancer
Dr Banerjee presents the history of the last 10 years in endometrial cancer (EC).

Credit available for this activity expires: 12/8/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999026?ecd=bdc_podcast_libsyn_mscpedu
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare

Avsnitt

Living With Endometrial Cancer: Understanding Patient Perspectives to Improve Overall Care

Beyond Primary Treatment: How Else Can We Benefit Our Patients Through a Holistic Approach to Care?

The Hottest Topic in Endometrial Cancer: Where Is the Therapeutic Landscape Moving to and What Are the Data to Support This?

To Combine or Not to Combine Chemotherapy and Immunotherapy, Is That the Question in Endometrial Cancer?

The Story So Far: The Long and Short of Clinical Development in Endometrial Cancer